This inventor holds 52 USPTO granted patents and 41 published patent applications, plus 4 CIPO patents and 6 EPO patents, primarily in Hormone Replacement Therapy (CPC class A61K). Top assignees: Therapeuticsmd, Inc., Other. Active years: 2013-2024.
Inventors with similar research interests:
Company Filing History:
51 out of 59 
1 out of 834,350 Years Active: 2013-2024
Areas of Expertise:
Title: The Innovations of Brian A. Bernick: A Trailblazer in Hormone Therapy Patents
Introduction: Brian A. Bernick, based in Boca Raton, FL, is a distinguished inventor with an impressive portfolio of 52 patents. His work primarily focuses on innovative hormone therapies, particularly in the realm of progesterone formulations and their applications. Through his groundbreaking inventions, Bernick has contributed significantly to the field of medicine, enhancing patient care and treatment efficacy.
Latest Patents: Bernick's recent patents highlight his expertise in creating effective hormone replacement therapies. One notable patent, "Progesterone formulations having a desirable PK profile," outlines formulations and methods that improve the pharmacokinetic parameters of progesterone administration. This innovation enables a reduction in the amount of progesterone needed, while still delivering the benefits typically associated with higher dosages. Another significant patent focuses on "Natural combination hormone replacement formulations and therapies." This patent presents a variety of estrogen and progesterone replacement therapies, including formulations such as solubilized estradiol and micronized progesterone combinations, designed to optimize patient outcomes.
Career Highlights: Over the years, Bernick has made remarkable strides in the pharmaceutical industry, particularly during his time at TherapeuticsMD, Inc. His career is marked by a dedication to advancing hormone therapy, making him a notable figure in his field. His inventions not only reflect his innovative spirit but also represent his commitment to improving healthcare solutions for patients in need.
Collaborations: Collaboration has been a key aspect of Bernick's career. He has worked alongside accomplished professionals, including Julia M. Amadio and Peter H. R. Persicaner. Together, they have contributed to the development of advanced therapies and formulations that have the potential to revolutionize hormone replacement treatments.
Conclusion: Brian A. Bernick continues to be an influential inventor in the realm of hormone therapies, with numerous patents that illustrate his innovative approach to medical challenges. His contributions are paving the way for more effective treatment options, ultimately enhancing patient care and health outcomes. With his ongoing work and collaborations, Bernick remains a vital player in the advancement of medical innovations.